The Efficacy of Retinoic Acid in Patients with Radioiodine-Refractory Thyroid Cancer: A Meta-analysis

被引：0
|
作者：
Shin, Seunghyeon [1 ]
Pak, Kyoungjune [1 ]
Kim, Seong-Jang [1 ]
Kim, In Joo [1 ]
机构：
[1] Pusan Natl Univ Hosp, Busan, South Korea
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1702
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Sorafenib in the treatment of radioiodine-refractory differentiated thyroid cancer: a meta-analysis
    Shen, Chen-Tian
    Qiu, Zhong-Ling
    Luo, Quan-Yong
    ENDOCRINE-RELATED CANCER, 2014, 21 (02) : 253 - 261
  • [2] Efficacy and safety of targeted therapeutics for patients with radioiodine-refractory differentiated thyroid cancer: Systematic review and network meta-analysis
    Ji, Xiaoyu
    Liang, Weili
    Lv, Guixu
    Ding, Changyuan
    Lai, Hong
    Li, Luchuan
    Zeng, Qingdong
    Lv, Bin
    Sheng, Lei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] BRAF V600E and Retinoic Acid in Radioiodine-Refractory Papillary Thyroid Cancer
    Groener, Jan Benedikt
    Gelen, Debora
    Mogler, Carolin
    Herpel, Esther
    Toth, Csaba
    Kender, Zoltan
    Peichl, Marco
    Haufe, Sabine
    Haberkorn, Uwe
    Sulaj, Alba
    Zemva, Johanna
    Kopf, Stefan
    Nawroth, Peter Paul
    Brune, Maik
    Rudofsky, Gottfried
    HORMONE AND METABOLIC RESEARCH, 2019, 51 (01) : 69 - 75
  • [4] Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial
    Kiyota, Naomi
    Robinson, Bruce
    Shah, Manisha
    Hoff, Ana O.
    Taylor, Matthew H.
    Li, Di
    Dutcus, Corina E.
    Lee, Eun Kyung
    Kim, Sung-Bae
    Tahara, Makoto
    THYROID, 2017, 27 (09) : 1135 - 1141
  • [5] Combined therapy with 131I and retinoic acid in Korean patients with radioiodine-refractory papillary thyroid cancer
    Oh, So Won
    Moon, Seung-hwan
    Park, Do Joon
    Cho, Bo Youn
    Jung, Kyeong Cheon
    Lee, Dong Soo
    Chung, June-Key
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (10) : 1798 - 1805
  • [6] Combined therapy with 131I and retinoic acid in Korean patients with radioiodine-refractory papillary thyroid cancer
    So Won Oh
    Seung-hwan Moon
    Do Joon Park
    Bo Youn Cho
    Kyeong Cheon Jung
    Dong Soo Lee
    June-Key Chung
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 1798 - 1805
  • [7] I-131 therapy with retinoic acid in patients with radioiodine-refractory papillary thyroid carcinoma
    Jo, Kyung Sook
    Lee, Su Jin
    Song, Hee Sung
    Yoon, Seok-Ho
    An, Yount-Sil
    Yoon, Joon-Kee
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [8] Lenvatinib in Radioiodine-Refractory Thyroid Cancer
    Lee, Hyo Jin
    Yun, Hwan-Jung
    Kim, Samyong
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (19): : 1868 - 1868
  • [9] Sorafenib and radioiodine-refractory differentiated thyroid cancer (RR-DTC): a systematic review and meta-analysis
    Feng, Guoli
    Luo, Yi
    Zhang, Qi
    Zeng, Feng
    Xu, Jie
    Zhu, Jingqiang
    ENDOCRINE, 2020, 68 (01) : 56 - 63
  • [10] Sorafenib and radioiodine-refractory differentiated thyroid cancer (RR-DTC): a systematic review and meta-analysis
    Guoli Feng
    Yi Luo
    Qi Zhang
    Feng Zeng
    Jie Xu
    Jingqiang Zhu
    Endocrine, 2020, 68 : 56 - 63
12345